These data indicate that IL‐1 signals – despite signal transduction – do not reconfigure the IL‐1R1 system by markedly increasing IL‐1R1 protein levels on hepatocytes and suggest that not receptor expression rather ligands are dysregulated in NAFLD. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.